80 FR 15793 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 57 (March 25, 2015)

Page Range		15793-15793
FR Document		2015-06850

Federal Register, Volume 80 Issue 57 (Wednesday, March 25, 2015)

[Federal Register Volume 80, Number 57 (Wednesday, March 25, 2015)]
[Notices]
[Page 15793]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06850]



[[Page 15793]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to (FOA) DD15-004, Stillbirth Risk Factor 
Pilot Project Centers for Birth Defects Research and Prevention 
(CBDRPs).

    Time and Date: 11:00 a.m.-6:00 p.m., April 21, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Stillbirth Risk Factor Pilot Project Centers for Birth 
Defects Research and Prevention (CBDRPs)'', FOA DD15-004.
    Contact Person for More Information: M. Chris Langub, Ph.D., 
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-06850 Filed 3-24-15; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 80, No. 57 / Wednesday, March 25, 2015 / Notices 15793

DEPARTMENT OF HEALTH AND as amended. The grant applications and The meeting will be closed to the
HUMAN SERVICES the discussions could disclose public in accordance with the
confidential trade secrets or commercial provisions set forth in section 552b(c)(4)
Centers for Disease Control and property such as patentable material, and 552b(c)(6), Title 5 U.S.C., as
Prevention and personal information concerning amended. The grant applications and
individuals associated with the grant the discussions could disclose
Disease, Disability, and Injury applications, the disclosure of which confidential trade secrets or commercial
Prevention and Control Special would constitute a clearly unwarranted property such as patentable material,
Emphasis Panel (SEP): Initial Review invasion of personal privacy. and personal information concerning
In accordance with Section 10(a)(2) of Name of Committee: Center for Scientific individuals associated with the grant
the Federal Advisory Committee Act Review Special Emphasis Panel; Pilot applications, the disclosure of which
(Pub. L. 92–463), the Centers for Disease Clinical Studies in Nephrology and Urology. would constitute a clearly unwarranted
Control and Prevention (CDC) Date: April 7, 2015. invasion of personal privacy.
announces a meeting for the initial Time: 2:00 p.m. to 5:00 p.m. Name of Committee: National Institute of
Agenda: To review and evaluate grant
review of applications in response to Child Health and Human Development
applications. Special Emphasis.
(FOA) DD15–004, Stillbirth Risk Factor Place: National Institutes of Health, 6701
Pilot Project Centers for Birth Defects Date: April 21, 2015.
Rockledge Drive, Bethesda, MD 20892, Time: 1:00 p.m. to 4:00 p.m.
Research and Prevention (CBDRPs). (Telephone Conference Call). Agenda: To review and evaluate grant
Time and Date: 11:00 a.m.–6:00 p.m., April Contact Person: Ryan G. Morris, Ph.D., applications.
21, 2015 (Closed). Scientific Review Officer, Center for Place: National Institutes of Health, 6100
Place: Teleconference. Scientific Review, National Institutes of Executive Boulevard, Rockville, MD 20852
Status: The meeting will be closed to the Health, 6701 Rockledge Drive, Room 4205, (Telephone Conference Call).
public in accordance with provisions set MSC 7814, Bethesda, MD 20892, 301–435– Contact Person: Sathasiva B. Kandasamy,
forth in Section 1501, morrisr@csr.nih.gov. Ph.D., Scientific Review Officer, Scientific
552b(c)(4) and (6), Title 5 U.S.C., and the This notice is being published less than 15 Review Branch, Eunice Kennedy Shriver
Determination of the Director, Management days prior to the meeting due to the timing National Institute of Child Health and
Analysis and Services Office, CDC, pursuant limitations imposed by the review and Human Development, NIH, 6100 Executive
to Public Law 92–463. funding cycle. Boulevard, Room 5B01, Bethesda, MD
Matters for Discussion: The meeting will Name of Committee: Center for Scientific 20892–9304, (301) 435–6680, skandasa@
include the initial review, discussion, and Review Special Emphasis Panel; Vascular mail.nih.gov.
evaluation of applications received in Biology and Hematology AREA. (Catalogue of Federal Domestic Assistance
response to ‘‘Stillbirth Risk Factor Pilot Date: April 17, 2015. Program Nos. 93.864, Population Research;
Project Centers for Birth Defects Research Time: 2:00 p.m. to 4:30 p.m. 93.865, Research for Mothers and Children;
and Prevention (CBDRPs)’’, FOA DD15–004. Agenda: To review and evaluate grant 93.929, Center for Medical Rehabilitation
Contact Person for More Information: M. applications. Research; 93.209, Contraception and
Chris Langub, Ph.D., Scientific Review Place: National Institutes of Health, 6701 Infertility Loan Repayment Program, National
Officer, CDC, 4770 Buford Highway NE., Rockledge Drive, Bethesda, MD 20892, Institutes of Health, HHS)
Mailstop F–80, Atlanta, Georgia 30341, (Telephone Conference Call).
Dated: March 20, 2015.
Telephone: (770) 488–3585, EEO6@cdc.gov. Contact Person: Larry Pinkus, Ph.D.,
The Director, Management Analysis and Scientific Review Officer, Center for Michelle Trout,
Services Office, has been delegated the Scientific Review, National Institutes of Program Analyst, Office of Federal Advisory
authority to sign Federal Register notices Health, 6701 Rockledge Drive, Room 4132, Committee Policy.
pertaining to announcements of meetings and MSC 7802, Bethesda, MD 20892, (301) 435– [FR Doc. 2015–06843 Filed 3–24–15; 8:45 am]
other committee management activities, for 1214, pinkusl@csr.nih.gov. BILLING CODE 4140–01–P
both the Centers for Disease Control and (Catalogue of Federal Domestic Assistance
Prevention and the Agency for Toxic Program Nos. 93.306, Comparative Medicine;
Substances and Disease Registry. 93.333, Clinical Research, 93.306, 93.333, DEPARTMENT OF HEALTH AND
93.337, 93.393–93.396, 93.837–93.844, HUMAN SERVICES
Catherine Ramadei,
93.846–93.878, 93.892, 93.893, National
Acting Director, Management Analysis and Institutes of Health, HHS)
Services Office, Centers for Disease Control National Institutes of Health
and Prevention. Dated: March 19, 2015.
Carolyn Baum, Eunice Kennedy Shriver National
[FR Doc. 2015–06850 Filed 3–24–15; 8:45 am]
Program Analyst, Office of Federal Advisory Institute of Child Health and Human
BILLING CODE 4163–18–P
Committee Policy. Development; Notice of Closed
[FR Doc. 2015–06840 Filed 3–24–15; 8:45 am] Meeting
DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P Pursuant to section 10(d) of the
HUMAN SERVICES Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
National Institutes of Health DEPARTMENT OF HEALTH AND hereby given of the following meeting.
HUMAN SERVICES The meeting will be closed to the
Center for Scientific Review; Notice of public in accordance with the
Closed Meetings National Institutes of Health provisions set forth in section 552b(c)(4)
Pursuant to section 10(d) of the and 552b(c)(6), Title 5 U.S.C., as
rljohnson on DSK3VPTVN1PROD with NOTICES

Eunice Kennedy Shriver National
Federal Advisory Committee Act, as Institute of Child Health and Human amended. The contract proposals and
amended (5 U.S.C. App.), notice is Development Notice of Closed Meeting the discussions could disclose
hereby given of the following meetings. confidential trade secrets or commercial
The meetings will be closed to the Pursuant to section 10(d) of the property such as patentable material,
public in accordance with the Federal Advisory Committee Act, as and personal information concerning
provisions set forth in sections amended (5 U.S.C. App.), notice is individuals associated with the contract
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., hereby given of the following meeting. proposals, the disclosure of which

VerDate Sep<11>2014 15:26 Mar 24, 2015 Jkt 235001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\25MRN1.SGM 25MRN1

Document Created: 2018-02-21 09:49:30
Document Modified: 2018-02-21 09:49:30

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		11:00 a.m.-6:00 p.m., April 21, 2015 (Closed).
FR Citation		80 FR 15793

80 FR 15793 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 57 (March 25, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention